Bpifrance Participations SA 13D/13G Filings for Millendo Therapeutics, Inc. (MLND)

Bpifrance Participations SA 13D and 13G filings for Millendo Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-07-30
11:12 am
Sale		 2020-07-23 13D Millendo Therapeutics, Inc.
MLND		 Bpifrance Participations SA 39,340
3.100%		 -32,571decrease
(-45.29%)		 Filing